跳轉至內容
Merck
  • Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells.

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells.

Oncotarget (2017-10-27)
Marina Willibald, Giuliano Bayer, Vanessa Stahlhut, Gereon Poschmann, Kai Stühler, Berthold Gierke, Michael Pawlak, Harald Seeger, Alfred O Mueck, Dieter Niederacher, Tanja Fehm, Hans Neubauer
摘要

Menopausal hormone therapy, using estrogen and synthetic progestins, is associated with an increased risk of developing breast cancer. The effect of progestins on breast cells is complex and not yet fully understood. In previous

材料
產品編號
品牌
產品描述

Sigma-Aldrich
醌茜素, ≥95% (HPLC)